DD Support Board and Research Team

[loanranger]

Thanks, but the issue wasn't related to "determining the appropriate accounting answer for general situations"...it was generally about the propriety of issuing shares to a party who might be in a position to color some clinical trial results in order to benefit from the effect that could have on the price of shares or options that they received as compensation.